New shot targets tough blood cancers in early trial
NCT ID NCT07338604
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new injection called UTAA07 for adults with CD7-positive blood cancers that have come back or not responded to treatment. The main goals are to check safety and find the best dose. Only 15 people will take part in this early-stage trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLYMPHOID MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Soochow University
RECRUITINGSuzhou, Jiangsu, 215000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.